APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Valsartan Market Outlook and Growth Opportunities 2026

30 December 2025203 pages

Choose your research edition.

Industry ResearchValsartan Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Valsartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Valsartan market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Valsartan market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Valsartan market include Alembic Pharmaceuticals, Amneal Pharmaceuticals, Aurobindo Pharma, HETERO, Huaren Pharmaceutical, Jubilant Pharma, LG Life Sciences, Lupin and Macleods Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan Segment by Company

Alembic Pharmaceuticals

Amneal Pharmaceuticals

Aurobindo Pharma

HETERO

Huaren Pharmaceutical

Jubilant Pharma

LG Life Sciences

Lupin

Macleods Pharmaceuticals

Square Pharmaceuticals

Torrent Pharmaceuticals

Unichem Laboratories

Mylan

Novartis

Sun Pharmaceutical

Teva

Zhejiang Huahai Pharmaceutical

Valsartan Segment by Type

80 mg Tablets

40 mg Tablets

320 mg Tablets

160 mg Tablets

Valsartan Segment by Application

Heart Failure

Heart Attack

Hypertension

Valsartan Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Valsartan status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Valsartan market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Valsartan significant trends, drivers, influence factors in global and regions.

6. To analyze Valsartan competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Valsartan industry.

Chapter 3: Detailed analysis of Valsartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Valsartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Valsartan in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Valsartan Industry Trends Table 2. Valsartan Industry Drivers Table 3. Valsartan Industry Opportunities and Challenges Table 4. Valsartan Industry Restraints Table 5. Global Valsartan Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Valsartan Revenue Share by Company (2021-2026) Table 7. Global Valsartan Sales Volume by Company (K Pcs) & (2021-2026) Table 8. Global Valsartan Sales Volume Share by Company (2021-2026) Table 9. Global Valsartan Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Valsartan Company Ranking, (2024-2026) & (USD Million) Table 11. Global Valsartan Key Company Manufacturing Base & Headquarters Table 12. Global Valsartan Company, Product Type & Application Table 13. Global Valsartan Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 80 mg Tablets Table 18. Significant Companies of 40 mg Tablets Table 19. Significant Companies of 320 mg Tablets Table 20. Significant Companies of 160 mg Tablets Table 21. Global Valsartan Sales Volume by Type 2021 VS 2025 VS 2032 (K Pcs) Table 22. Global Valsartan Sales Volume by Type (2021-2026) & (K Pcs) Table 23. Global Valsartan Sales Volume by Type (2027-2032) & (K Pcs) Table 24. Global Valsartan Sales Volume Share by Type (2021-2026) Table 25. Global Valsartan Sales Volume Share by Type (2027-2032) Table 26. Global Valsartan Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Valsartan Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Valsartan Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Valsartan Sales Value Share by Type (2021-2026) Table 30. Global Valsartan Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Heart Failure Table 32. Significant Companies of Heart Attack Table 33. Significant Companies of Hypertension Table 34. Global Valsartan Sales Volume by Application 2021 VS 2025 VS 2032 (K Pcs) Table 35. Global Valsartan Sales Volume by Application (2021-2026) & (K Pcs) Table 36. Global Valsartan Sales Volume by Application (2027-2032) & (K Pcs) Table 37. Global Valsartan Sales Volume Share by Application (2021-2026) Table 38. Global Valsartan Sales Volume Share by Application (2027-2032) Table 39. Global Valsartan Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Valsartan Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Valsartan Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Valsartan Sales Value Share by Application (2021-2026) Table 43. Global Valsartan Sales Value Share by Application (2027-2032) Table 44. Global Valsartan Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 45. Global Valsartan Sales by Region (2021-2026) & (K Pcs) Table 46. Global Valsartan Sales Market Share by Region (2021-2026) Table 47. Global Valsartan Sales by Region (2027-2032) & (K Pcs) Table 48. Global Valsartan Sales Market Share by Region (2027-2032) Table 49. Global Valsartan Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Valsartan Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Valsartan Sales Value Share by Region (2021-2026) Table 52. Global Valsartan Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Valsartan Sales Value Share by Region (2027-2032) Table 54. Global Valsartan Market Average Price (US$/Pcs) by Region (2021-2026) Table 55. Global Valsartan Market Average Price (US$/Pcs) by Region (2027-2032) Table 56. Global Valsartan Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 57. Global Valsartan Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Valsartan Sales by Country (2021-2026) & (K Pcs) Table 59. Global Valsartan Sales Market Share by Country (2021-2026) Table 60. Global Valsartan Sales by Country (2027-2032) & (K Pcs) Table 61. Global Valsartan Sales Market Share by Country (2027-2032) Table 62. Global Valsartan Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Valsartan Sales Value Market Share by Country (2021-2026) Table 64. Global Valsartan Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Valsartan Sales Value Market Share by Country (2027-2032) Table 66. Alembic Pharmaceuticals Company Information Table 67. Alembic Pharmaceuticals Business Overview Table 68. Alembic Pharmaceuticals Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 69. Alembic Pharmaceuticals Valsartan Product Portfolio Table 70. Alembic Pharmaceuticals Recent Development Table 71. Amneal Pharmaceuticals Company Information Table 72. Amneal Pharmaceuticals Business Overview Table 73. Amneal Pharmaceuticals Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 74. Amneal Pharmaceuticals Valsartan Product Portfolio Table 75. Amneal Pharmaceuticals Recent Development Table 76. Aurobindo Pharma Company Information Table 77. Aurobindo Pharma Business Overview Table 78. Aurobindo Pharma Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 79. Aurobindo Pharma Valsartan Product Portfolio Table 80. Aurobindo Pharma Recent Development Table 81. HETERO Company Information Table 82. HETERO Business Overview Table 83. HETERO Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 84. HETERO Valsartan Product Portfolio Table 85. HETERO Recent Development Table 86. Huaren Pharmaceutical Company Information Table 87. Huaren Pharmaceutical Business Overview Table 88. Huaren Pharmaceutical Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 89. Huaren Pharmaceutical Valsartan Product Portfolio Table 90. Huaren Pharmaceutical Recent Development Table 91. Jubilant Pharma Company Information Table 92. Jubilant Pharma Business Overview Table 93. Jubilant Pharma Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 94. Jubilant Pharma Valsartan Product Portfolio Table 95. Jubilant Pharma Recent Development Table 96. LG Life Sciences Company Information Table 97. LG Life Sciences Business Overview Table 98. LG Life Sciences Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 99. LG Life Sciences Valsartan Product Portfolio Table 100. LG Life Sciences Recent Development Table 101. Lupin Company Information Table 102. Lupin Business Overview Table 103. Lupin Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 104. Lupin Valsartan Product Portfolio Table 105. Lupin Recent Development Table 106. Macleods Pharmaceuticals Company Information Table 107. Macleods Pharmaceuticals Business Overview Table 108. Macleods Pharmaceuticals Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 109. Macleods Pharmaceuticals Valsartan Product Portfolio Table 110. Macleods Pharmaceuticals Recent Development Table 111. Square Pharmaceuticals Company Information Table 112. Square Pharmaceuticals Business Overview Table 113. Square Pharmaceuticals Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 114. Square Pharmaceuticals Valsartan Product Portfolio Table 115. Square Pharmaceuticals Recent Development Table 116. Torrent Pharmaceuticals Company Information Table 117. Torrent Pharmaceuticals Business Overview Table 118. Torrent Pharmaceuticals Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 119. Torrent Pharmaceuticals Valsartan Product Portfolio Table 120. Torrent Pharmaceuticals Recent Development Table 121. Unichem Laboratories Company Information Table 122. Unichem Laboratories Business Overview Table 123. Unichem Laboratories Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 124. Unichem Laboratories Valsartan Product Portfolio Table 125. Unichem Laboratories Recent Development Table 126. Mylan Company Information Table 127. Mylan Business Overview Table 128. Mylan Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 129. Mylan Valsartan Product Portfolio Table 130. Mylan Recent Development Table 131. Novartis Company Information Table 132. Novartis Business Overview Table 133. Novartis Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 134. Novartis Valsartan Product Portfolio Table 135. Novartis Recent Development Table 136. Sun Pharmaceutical Company Information Table 137. Sun Pharmaceutical Business Overview Table 138. Sun Pharmaceutical Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 139. Sun Pharmaceutical Valsartan Product Portfolio Table 140. Sun Pharmaceutical Recent Development Table 141. Teva Company Information Table 142. Teva Business Overview Table 143. Teva Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 144. Teva Valsartan Product Portfolio Table 145. Teva Recent Development Table 146. Zhejiang Huahai Pharmaceutical Company Information Table 147. Zhejiang Huahai Pharmaceutical Business Overview Table 148. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 149. Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio Table 150. Zhejiang Huahai Pharmaceutical Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Valsartan Distributors List Table 154. Valsartan Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Valsartan Product Image Figure 2. Global Valsartan Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Sales Value (2021-2032) & (US$ Million) Figure 4. Global Valsartan Sales (2021-2032) & (K Pcs) Figure 5. Global Valsartan Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Valsartan Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 80 mg Tablets Image Figure 10. 40 mg Tablets Image Figure 11. 320 mg Tablets Image Figure 12. 160 mg Tablets Image Figure 13. Global Valsartan Sales Volume by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 14. Global Valsartan Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Valsartan Sales Volume Share by Type (2021-2032) Figure 16. Global Valsartan Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Valsartan Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Valsartan Sales Value Share by Type (2021-2032) Figure 19. Heart Failure Image Figure 20. Heart Attack Image Figure 21. Hypertension Image Figure 22. Global Valsartan Sales Volume by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 23. Global Valsartan Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Valsartan Sales Volume Share by Application (2021-2032) Figure 25. Global Valsartan Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Valsartan Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Valsartan Sales Value Share by Application (2021-2032) Figure 28. Global Valsartan Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 29. Global Valsartan Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Valsartan Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Valsartan Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Valsartan Sales Value (2021-2032) & (US$ Million) Figure 33. North America Valsartan Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Valsartan Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Valsartan Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Valsartan Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Valsartan Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Valsartan Sales Value (2021-2032) & (US$ Million) Figure 39. South America Valsartan Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Valsartan Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Valsartan Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Valsartan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Valsartan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Valsartan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Valsartan Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Valsartan Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 80 mg Tablets
  • 40 mg Tablets
  • 320 mg Tablets
  • 160 mg Tablets
Applications
  • Heart Failure
  • Heart Attack
  • Hypertension
Companies covered
  • Alembic Pharmaceuticals
  • Amneal Pharmaceuticals
  • Aurobindo Pharma
  • HETERO
  • Huaren Pharmaceutical
  • Jubilant Pharma
  • LG Life Sciences
  • Lupin
  • Macleods Pharmaceuticals
  • Square Pharmaceuticals
  • Torrent Pharmaceuticals
  • Unichem Laboratories
  • Mylan
  • Novartis
  • Sun Pharmaceutical
  • Teva
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valsartan Sales Value (2021-2032)
  4. 1.2.2 Global Valsartan Sales Volume (2021-2032)
  5. 1.2.3 Global Valsartan Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Valsartan Market Dynamics
  1. 2.1 Valsartan Industry Trends
  2. 2.2 Valsartan Industry Drivers
  3. 2.3 Valsartan Industry Opportunities and Challenges
  4. 2.4 Valsartan Industry Restraints
3 Valsartan Market by Company
  1. 3.1 Global Valsartan Company Revenue Ranking in 2025
  2. 3.2 Global Valsartan Revenue by Company (2021-2026)
  3. 3.3 Global Valsartan Sales Volume by Company (2021-2026)
  4. 3.4 Global Valsartan Average Price by Company (2021-2026)
  5. 3.5 Global Valsartan Company Ranking (2024-2026)
  6. 3.6 Global Valsartan Company Manufacturing Base and Headquarters
  7. 3.7 Global Valsartan Company Product Type and Application
  8. 3.8 Global Valsartan Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Valsartan Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Valsartan Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Valsartan Market by Type
  1. 4.1 Valsartan Type Introduction
  2. 4.1.1 80 mg Tablets
  3. 4.1.2 40 mg Tablets
  4. 4.1.3 320 mg Tablets
  5. 4.1.4 160 mg Tablets
  6. 4.2 Global Valsartan Sales Volume by Type
  7. 4.2.1 Global Valsartan Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Valsartan Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Valsartan Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Valsartan Sales Value by Type
  11. 4.3.1 Global Valsartan Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Valsartan Sales Value by Type (2021-2032)
  13. 4.3.3 Global Valsartan Sales Value Share by Type (2021-2032)
5 Valsartan Market by Application
  1. 5.1 Valsartan Application Introduction
  2. 5.1.1 Heart Failure
  3. 5.1.2 Heart Attack
  4. 5.1.3 Hypertension
  5. 5.2 Global Valsartan Sales Volume by Application
  6. 5.2.1 Global Valsartan Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Valsartan Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Valsartan Sales Value by Application
  10. 5.3.1 Global Valsartan Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Valsartan Sales Value by Application (2021-2032)
  12. 5.3.3 Global Valsartan Sales Value Share by Application (2021-2032)
6 Valsartan Regional Sales and Value Analysis
  1. 6.1 Global Valsartan Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan Sales by Region: 2021-2026
  4. 6.2.2 Global Valsartan Sales by Region (2027-2032)
  5. 6.3 Global Valsartan Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Valsartan Sales Value by Region (2021-2032)
  7. 6.4.1 Global Valsartan Sales Value by Region: 2021-2026
  8. 6.4.2 Global Valsartan Sales Value by Region (2027-2032)
  9. 6.5 Global Valsartan Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Valsartan Sales Value (2021-2032)
  12. 6.6.2 North America Valsartan Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Valsartan Sales Value (2021-2032)
  15. 6.7.2 Europe Valsartan Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Valsartan Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Valsartan Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Valsartan Sales Value (2021-2032)
  21. 6.9.2 South America Valsartan Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Valsartan Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Valsartan Sales Value Share by Country, 2025 VS 2032
7 Valsartan Country-level Sales and Value Analysis
  1. 7.1 Global Valsartan Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Valsartan Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Valsartan Sales by Country (2021-2032)
  4. 7.3.1 Global Valsartan Sales by Country (2021-2026)
  5. 7.3.2 Global Valsartan Sales by Country (2027-2032)
  6. 7.4 Global Valsartan Sales Value by Country (2021-2032)
  7. 7.4.1 Global Valsartan Sales Value by Country (2021-2026)
  8. 7.4.2 Global Valsartan Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Valsartan Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Valsartan Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Valsartan Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Valsartan Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Valsartan Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Valsartan Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Valsartan Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Valsartan Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Valsartan Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Valsartan Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Valsartan Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Valsartan Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Valsartan Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Valsartan Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Valsartan Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Valsartan Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Valsartan Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Valsartan Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Valsartan Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Valsartan Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Valsartan Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Valsartan Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Valsartan Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Valsartan Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Valsartan Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Valsartan Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Valsartan Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Valsartan Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Valsartan Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Valsartan Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Valsartan Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Valsartan Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Valsartan Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Valsartan Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Valsartan Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Valsartan Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Valsartan Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Valsartan Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Valsartan Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Valsartan Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Valsartan Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Valsartan Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Valsartan Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Valsartan Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Valsartan Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Valsartan Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Valsartan Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Valsartan Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Valsartan Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Valsartan Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Valsartan Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Valsartan Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Valsartan Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Valsartan Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Valsartan Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Valsartan Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Valsartan Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Valsartan Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Valsartan Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Valsartan Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Valsartan Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Valsartan Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Valsartan Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Valsartan Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Valsartan Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Valsartan Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Valsartan Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Valsartan Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Valsartan Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Valsartan Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Valsartan Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Valsartan Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Valsartan Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Valsartan Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Valsartan Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Valsartan Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Valsartan Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Valsartan Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Valsartan Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Valsartan Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Valsartan Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Valsartan Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Valsartan Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Valsartan Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic Pharmaceuticals
  2. 8.1.1 Alembic Pharmaceuticals Company Information
  3. 8.1.2 Alembic Pharmaceuticals Business Overview
  4. 8.1.3 Alembic Pharmaceuticals Valsartan Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Pharmaceuticals Valsartan Product Portfolio
  6. 8.1.5 Alembic Pharmaceuticals Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Valsartan Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Valsartan Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Aurobindo Pharma
  14. 8.3.1 Aurobindo Pharma Company Information
  15. 8.3.2 Aurobindo Pharma Business Overview
  16. 8.3.3 Aurobindo Pharma Valsartan Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Aurobindo Pharma Valsartan Product Portfolio
  18. 8.3.5 Aurobindo Pharma Recent Developments
  19. 8.4 HETERO
  20. 8.4.1 HETERO Company Information
  21. 8.4.2 HETERO Business Overview
  22. 8.4.3 HETERO Valsartan Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 HETERO Valsartan Product Portfolio
  24. 8.4.5 HETERO Recent Developments
  25. 8.5 Huaren Pharmaceutical
  26. 8.5.1 Huaren Pharmaceutical Company Information
  27. 8.5.2 Huaren Pharmaceutical Business Overview
  28. 8.5.3 Huaren Pharmaceutical Valsartan Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Huaren Pharmaceutical Valsartan Product Portfolio
  30. 8.5.5 Huaren Pharmaceutical Recent Developments
  31. 8.6 Jubilant Pharma
  32. 8.6.1 Jubilant Pharma Company Information
  33. 8.6.2 Jubilant Pharma Business Overview
  34. 8.6.3 Jubilant Pharma Valsartan Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jubilant Pharma Valsartan Product Portfolio
  36. 8.6.5 Jubilant Pharma Recent Developments
  37. 8.7 LG Life Sciences
  38. 8.7.1 LG Life Sciences Company Information
  39. 8.7.2 LG Life Sciences Business Overview
  40. 8.7.3 LG Life Sciences Valsartan Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LG Life Sciences Valsartan Product Portfolio
  42. 8.7.5 LG Life Sciences Recent Developments
  43. 8.8 Lupin
  44. 8.8.1 Lupin Company Information
  45. 8.8.2 Lupin Business Overview
  46. 8.8.3 Lupin Valsartan Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Valsartan Product Portfolio
  48. 8.8.5 Lupin Recent Developments
  49. 8.9 Macleods Pharmaceuticals
  50. 8.9.1 Macleods Pharmaceuticals Company Information
  51. 8.9.2 Macleods Pharmaceuticals Business Overview
  52. 8.9.3 Macleods Pharmaceuticals Valsartan Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Macleods Pharmaceuticals Valsartan Product Portfolio
  54. 8.9.5 Macleods Pharmaceuticals Recent Developments
  55. 8.10 Square Pharmaceuticals
  56. 8.10.1 Square Pharmaceuticals Company Information
  57. 8.10.2 Square Pharmaceuticals Business Overview
  58. 8.10.3 Square Pharmaceuticals Valsartan Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Square Pharmaceuticals Valsartan Product Portfolio
  60. 8.10.5 Square Pharmaceuticals Recent Developments
  61. 8.11 Torrent Pharmaceuticals
  62. 8.11.1 Torrent Pharmaceuticals Company Information
  63. 8.11.2 Torrent Pharmaceuticals Business Overview
  64. 8.11.3 Torrent Pharmaceuticals Valsartan Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Torrent Pharmaceuticals Valsartan Product Portfolio
  66. 8.11.5 Torrent Pharmaceuticals Recent Developments
  67. 8.12 Unichem Laboratories
  68. 8.12.1 Unichem Laboratories Company Information
  69. 8.12.2 Unichem Laboratories Business Overview
  70. 8.12.3 Unichem Laboratories Valsartan Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Unichem Laboratories Valsartan Product Portfolio
  72. 8.12.5 Unichem Laboratories Recent Developments
  73. 8.13 Mylan
  74. 8.13.1 Mylan Company Information
  75. 8.13.2 Mylan Business Overview
  76. 8.13.3 Mylan Valsartan Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Mylan Valsartan Product Portfolio
  78. 8.13.5 Mylan Recent Developments
  79. 8.14 Novartis
  80. 8.14.1 Novartis Company Information
  81. 8.14.2 Novartis Business Overview
  82. 8.14.3 Novartis Valsartan Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Novartis Valsartan Product Portfolio
  84. 8.14.5 Novartis Recent Developments
  85. 8.15 Sun Pharmaceutical
  86. 8.15.1 Sun Pharmaceutical Company Information
  87. 8.15.2 Sun Pharmaceutical Business Overview
  88. 8.15.3 Sun Pharmaceutical Valsartan Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sun Pharmaceutical Valsartan Product Portfolio
  90. 8.15.5 Sun Pharmaceutical Recent Developments
  91. 8.16 Teva
  92. 8.16.1 Teva Company Information
  93. 8.16.2 Teva Business Overview
  94. 8.16.3 Teva Valsartan Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Teva Valsartan Product Portfolio
  96. 8.16.5 Teva Recent Developments
  97. 8.17 Zhejiang Huahai Pharmaceutical
  98. 8.17.1 Zhejiang Huahai Pharmaceutical Company Information
  99. 8.17.2 Zhejiang Huahai Pharmaceutical Business Overview
  100. 8.17.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio
  102. 8.17.5 Zhejiang Huahai Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan Value Chain Analysis
  2. 9.1.1 Valsartan Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan Sales Mode & Process
  6. 9.2 Valsartan Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan Distributors
  9. 9.2.3 Valsartan Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst